Physician profile
William A Willis
NPI 1205875846
$1,012.17
in general payments reported to CMS, 2019-2025
20 companies · $8.92 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $102 · 2021: $376 · 2022: $56.39 · 2023: $105 · 2024: $160 · 2025: $8.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $218.19 | 2021-2024 | Vraylar |
| Glaxosmithkline, LLC. | $126.21 | 2019-2023 | Trelegy Ellipta |
| Portola Pharmaceuticals, LLC | $103.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $87.52 | 2020-2024 | Airsupra |
| Pfizer INC. | $77.80 | 2019-2024 | |
| Exact Sciences Corporation | $71.23 | 2023-2024 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $48.90 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $48.28 | 2024 | Gemtesa |
| Allergan, INC. | $37.96 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $37.30 | 2021 | |
| Amarin Pharma, INC. | $23.70 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.18 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.85 | 2024 | |
| Boston Scientific Corporation | $16.83 | 2021 | |
| Amgen INC. | $15.93 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.29 | 2021 | |
| Lilly USA, LLC | $14.74 | 2024 | Mounjaro |
| Abbott Laboratories | $12.35 | 2021 | |
| Smith+Nephew, INC. | $11.99 | 2021 | |
| Axsome Therapeutics, INC. | $8.92 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.